Regulation of hepatic cytochrome P-450 during infectious disease.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Canadian Journal of Physiology and Pharmacology

• Publication date

  1990-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1139/Y90-119PMID 1695539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction and depression of cytochrome P-450-dependent mixed-function oxidase by a cloned consensus alpha-interferon (IFN-alpha CON1) in the hamster.

  1989cited by this paper
• Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: a comparison with lymphotoxin and interferon.

  1988cited by this paper
• Role of xanthine oxidase in the interferon-mediated depression of the hepatic cytochrome P-450 system in mice.

  1988cited by this paper
• Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family.

  1987cited by this paper
• Depression of cytochrome P-450 and alterations of protein metabolism in mice treated with the interferon inducer polyriboinosinic acid X polyribocytidylic acid.

  1986cited by this paper
• The pharmacology and toxicology of the interferons: an overview.

  1986cited by this paper
• Effect of Murine Gamma-Interferon on the Mouse Liver and Its Drug-Metabolizing Enzymes: Comparison with Human Hybrid Alpha-Interferon

  1985cited by this paper
• Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice.

  1985cited by this paper
• Interferon reduces hepatic drug metabolism in vivo in mice.

  1985cited by this paper
• Biochemical pathways in interferon-action.

  1984cited by this paper
• Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450.

  1984cited by this paper
• Inhibition of the synthesis of hepatic cytochrome P-450 by the interferon-inducing agent poly rI.rCi.

  1984cited by this paper
• Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers.

  1984cited by this paper
• Effect of Interferon on Murine Cytochrome P-450: Effect of Partially Purified Antigen-Specific Interferon-Gamma

  1983cited by this paper
• Effects of three recombinant human leukocyte interferons on drug metabolism in mice.

  1982cited by this paper
• Biochemistry of interferons and their actions.

  1982cited by this paper
• The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.

  1982cited by this paper
• Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation.

  1982cited by this paper
• Altered theophylline clearance during an influenza B outbreak.

  1982cited by this paper
• Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation.

  1981cited by this paper
• Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus.

  1981cited by this paper
• Effect of interferon inducing agents (polyriboinosinic acid . polyribocytidylic acid and tilorone) on the heme turnover of hepatic cytochrome P-450.

  1980cited by this paper
• ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESS

  1978cited by this paper
• Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride).

  1976cited by this paper
• Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride.

  1976cited by this paper
• Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents.

  1976cited by this paper

• The importance of therapeutic monitoring of theophylline

  2025cites this paper
• Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy

  2023cites this paper
• Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)

  2022cites this paper
• ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential

  2021cites this paper
• COVİD-19 da Sitokinler ve COVİD- 19 Tedavisinde Kullanılan İlaçlar Arasında Potansiyel İlaç Etkileşimleri.

  2021cites this paper
• The effect of ZnO nanoparticles on liver function in rats

  2016cites this paper
• Effects of Quercetin on CYP450 and Cytokines in Aroclor 1254 Injured Endometrial Cells of the Pregnant Rats

  2014cites this paper
• The Role of Drug Metabolism in Toxicity

  2010cites this paper
• Variability in drug metabolizing enzyme activity in HIV-infected patients

  2010influential citation
• Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing

  2008cites this paper
• Effect of Sulfur Dioxide Inhalation on CYP2B1/2 and CYP2E1 in Rat Liver and Lung

  2006cites this paper
• In vivo effects of chronic contamination with depleted uranium on CYP3A and associated nuclear receptors PXR and CAR in the rat.

  2005cites this paper
• Plasma hydroxy-metronidazole/metronidazole ratio in hepatitis C virus-induced liver disease.

  2005cites this paper
• Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.

  2005cites this paper
• Helicobacter pylori Infection Is Associated with Greater Impairment of Cytochrome P-450 Liver Metabolic Activity in Anti-HCV Positive Cirrhotic Patients

  2003cites this paper
• Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.

  2003cites this paper
• Allergic adverse reactions to sulfonamides

  2002cites this paper
• Loss of glutathione S-transferase (GST) mu phenotype in colorectal adenocarcinomas from patients with a GSTM1 positive genotype.

  2002cites this paper
• Cyclosporin A‐induced free radical generation is not mediated by cytochrome P‐450

  2002cites this paper
• Alteration of drug biotransformation and elimination during infection and inflammation.

  2001cites this paper
• Interactions among drugs for HIV and opportunistic infections.

  2001cites this paper
• Impairment of cytochrome P‐450‐dependent liver activity in cirrhotic patients with Helicobacter pylori infection

  2001cites this paper
• Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis-B virus does not occur in rapid acetylators

  2001cites this paper
• Hepatic cytochrome P450 regulation in disease states.

  2001cites this paper
• I NTERACTIONS AMONG D RUGS FOR HIV AND O PPORTUNISTIC I NFECTIONS

  2001cites this paper
• Use of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver.

  2000cites this paper
• Hepatic drug metabolism and immunostimulation.

  2000cites this paper
• The expression and regulation of drug metabolism in human placenta.

  1999cites this paper
• Xenobiotic-metabolizing enzymes in carp (Cyprinus carpio) liver, spleen, and head kidney following experimental Listeria monocytogenes infection.

  1999cites this paper
• Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokines.

  1999cites this paper
• Lipopolysaccharide evokes the modulation of brain cytochrome P4501A in the rat.

  1999cites this paper
• Plasma esterases in cystic fibrosis: the impact of a respiratory exacerbation and its treatment

  1999cites this paper
• Alteration in Indinavir Clearance During Interleukin‐2 Infusions in Patients Infected with the Human Immunodeficiency Virus

  1998cites this paper
• Endotoxin suppresses the oltipraz‐mediated induction of major hepatic glutathione transferases and cytochromes P450 in the rat

  1998cites this paper
• Non-clinical safety studies for biotechnologically-derived pharmaceuticals: conclusions from an International Workshop

  1998cites this paper
• Marked inhibition of hepatic cytochrome P450 activity in cholesterol-induced atherosclerosis in rabbits.

  1998cites this paper
• Designing non-clinical safety evaluation programmes for interferons and interleukins: Past experiences and recommendations for future products

  1998cites this paper
• Comparative effects of cytokines on constitutive and inducible expression of the gene encoding for the cytochrome P450 3A6 isoenzyme in cultured rabbit hepatocytes: consequences on progesterone 6beta-hydroxylation.

  1998cites this paper
• Mechanisms of signal transduction in the stress response of hepatocytes.

  1998cites this paper
• The Effect of Pulmonary Infection (Actinobacillus Pleuropneumoniae), Endotoxin and Dexamethasone on Enrofloxacin Pharmacokinetic Parameters in Swine.

  1998cites this paper
• Identification of glutathione S‐transferase isozymes and γ‐glutamylcysteine synthetase as negative acute‐phase proteins in rat liver

  1998cites this paper
• Effect of Interleukins on UGT2B15 and UGT2B17 Steroid Uridine Diphosphate-Glucuronosyltransferase Expression and Activity in the LNCaP Cell Line.

  1998cites this paper
• Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line.

  1998cites this paper
• Plasma hydroxy metronidazole/metronidazole ratio in anti-HCV carriers with and without apparent liver disease.

  1998cites this paper
• Intrahepatic cholestasis of pregnancy impairs the activities of human placental xenobiotic and steroid metabolizing enzymes in vitro.

  1997cites this paper
• Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes.

  1997cites this paper
• Increased drug reactions in HIV‐1‐positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV‐1 disease *

  1997cites this paper
• Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction.

  1997cites this paper
• The Effect of the Acute-Phase Response on In Vitro Drug Metabolism and Plasma Protein Binding in the Horse

  1997influential citation
• Role of Viral Infections in the Induction of Adverse Drug Reactions

  1997cites this paper
• Nitric Oxide-Mediated Inhibition of Cytochrome P450 by Interferon-γ in Human Hepatocytes

  1997cites this paper
• Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes.

  1997cites this paper
• Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-α/β induction

  1997cites this paper
• Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus

  1997cites this paper
• Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression.

  1997cites this paper
• Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus.

  1997cites this paper
• Effect of transforming growth factor-beta1 on expression of aryl hydrocarbon receptor and genes of Ah gene battery: clues for independent down-regulation in A549 cells.

  1997cites this paper
• Modulation of Glutathione S-Transferase Subunits A2, M1, and P1 Expression by Interleukin-1β in Rat Hepatocytes in Primary Culture*

  1997cites this paper
• Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.

  1997cites this paper
• OKT3 therapy increases cyclosporine blood levels

  1997cites this paper
• Pharmacokinetic Studies with Recombinant Cytokines

  1997cites this paper
• Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes.

  1996cites this paper
• Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450.

  1996cites this paper
• Nitric Oxide Mediates Hepatic Cytochrome P450 Dysfunction Induced by Endotoxin

  1996cites this paper
• Adverse reactions to trimethoprim-sulfamethoxazole.

  1996cites this paper
• Increased resistance to acetaminophen-induced hepatotoxicity in retrovirus-infected mice.

  1996cites this paper
• Chromatographic separation and behavior of microsomal cytochrome P450 and cytochrome b5.

  1996cites this paper
• Differential induction of carcinogen metabolizing enzymes in a transgenic mouse model of fulminant hepatitis

  1996cites this paper
• Adverse reactions to trimethoprim-sulfamethoxazole

  1996cites this paper
• Differential effect of interleukin-1 alpha on rat hepatic cytochrome P450 monooxygenases.

  1996cites this paper
• Cytochromes P450 and Liver Injury

  1996cites this paper
• Developmental Aspects of Drug Metabolism in Children

  1996cites this paper
• Drug interactions in patients infected with human immunodeficiency virus.

  1996cites this paper
• Interferon γ down‐regulates cytochrome P450 3A genes in primary cultures of well‐differentiated rat hepatocytes

  1996cites this paper
• Overexpression of Cytochrome P-450 Isoforms Involved in Aflatoxin B1 Bioactivation in Human Liver with Cirrhosis and Hepatitis

  1996cites this paper
• Differential effect of interleukin-1α on rat hepatic cytochrome P450 monooxygenases

  1996cites this paper
• Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes

  1996cites this paper
• Effects of phenobarbital and interleukin-6 on cytochrome P4502B1 and 2B2 in cultured rat hepatocytes.

  1996cites this paper
• The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation.

  1995cites this paper
• Effects of human recombinant interferon-alpha 2b on P450-dependent isozymes in rat liver and skin.

  1995cites this paper
• Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig.

  1995cites this paper
• Liver transplantation induces cytochrome P450 1A1 dependent monooxygenase activity in rat lung and kidney.

  1995cites this paper
• Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological, and therapeutic aspects.

  1995cites this paper
• Effects of simulated nuclear fuel particles on the histopathology and CYP enzymes in the rat lung and liver.

  1995cites this paper
• The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity.

  1995cites this paper
• Interferon-mediated changes in the expression of CYP1A1 in human B lymphoblastoid (AHH-1 TK +/-) cells.

  1995cites this paper
• Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.

  1995cites this paper
• Interleukin-1 beta antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture.

  1995cites this paper
• Interleukin‐1β antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture

  1995cites this paper
• Pro‐inflammatory cytokines in a ruminant model: Pathophysiological, pharmacological, and therapeutic aspects

  1995cites this paper
• Mechanisms of interferon mediated downregulation of cytochrome P450 enzymes.

  1995cites this paper
• Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice

  1994cites this paper
• Modulation of growth factor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

  1994cites this paper
• Role of Environmental Factors in the Pharmacokinetics of Drugs: Considerations with Respect to Animal Models, P-450 Enzymes, and Probe Drugs

  1994cites this paper
• Suppression of cytochrome P450IA1 by interleukin-6 in human HepG2 hepatoma cells.

  1994cites this paper
• Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat during the production of interferon alpha/beta.

  1994cites this paper
• Factors involved in the down-regulation of cytochrome P450 during Listeria monocytogenes infection.

  1994cites this paper
• [Intracellular oxygen activation and molecular mechanisms of oxidative hepatic damage].

  1994cites this paper
• Assessment of host resistance to Trichinella spiralis in mice following preinfection exposure to 2,3,7,8-TCDD.

  1994cites this paper
• Metabolism of caffeine and theophylline in rats with malaria and endotoxin-induced fever.

  1993cites this paper